Search Results

You are looking at 1 - 2 of 2 items for

  • Author: F. Takao x
  • Refine by access: All content x
Clear All Modify Search
Takao Ando Thyroid Research Unit, Mount Sinai School of Medicine, The James J Peters VA Medical Center, Box 1055, 1 Gustave L Levy Place, New York, New York 10029, USA

Search for other papers by Takao Ando in
Google Scholar
PubMed
Close
,
Rauf Latif Thyroid Research Unit, Mount Sinai School of Medicine, The James J Peters VA Medical Center, Box 1055, 1 Gustave L Levy Place, New York, New York 10029, USA

Search for other papers by Rauf Latif in
Google Scholar
PubMed
Close
, and
Terry F Davies Thyroid Research Unit, Mount Sinai School of Medicine, The James J Peters VA Medical Center, Box 1055, 1 Gustave L Levy Place, New York, New York 10029, USA

Search for other papers by Terry F Davies in
Google Scholar
PubMed
Close

The post-translational processing of the TSH receptor (TSHR) includes intra-molecular cleavage with the loss of a 50 amino acid ectodomain region and the formation of two subunits (α and β), followed by likely α subunit shedding. TSHR antibodies (TSHR-Abs), which are directed at the ectodomain, may influence thyroid function by stimulating or inhibiting TSHR signaling or may bind without any such influence (the neutral group of antibodies). When we examined the characteristics of a series of monoclonal TSHR-Abs, we found that many were able to inhibit receptor cleavage and enhance TSHR expression. This was especially apparent with the neutral type of TSHR-Abs directed to the cleaved region of the ectodomain (aa 316–366). Indeed, such inhibition appeared to be epitope dependent with TSHR-Abs directed to regions after residues 335–354 showing no such activity. We propose that this aberrant process, whereby TSHR-Abs influence antigen processing, is a novel mechanism for the maintenance and exacerbation of autoimmune thyroid disease.

Free access
F. Takao
Search for other papers by F. Takao in
Google Scholar
PubMed
Close
,
S. Kagawa
Search for other papers by S. Kagawa in
Google Scholar
PubMed
Close
,
K. Sakamoto
Search for other papers by K. Sakamoto in
Google Scholar
PubMed
Close
, and
A. Matsuoka
Search for other papers by A. Matsuoka in
Google Scholar
PubMed
Close

ABSTRACT

The effect of maternal hyperglycaemia on the function of neonatal B cells was examined using a perifusion technique in pancreatic monolayer cultures of neonatal rats from normoglycaemic mothers (C), and those made slightly hyperglycaemic (SH) and highly hyperglycaemic (HH) by injection of streptozotocin. Monolayer cultures were kept for 7 days in medium containing 5·5 mmol glucose/l plus 1 mmol 2-deoxy-glucose/l. On day 0, B cells in the C group responded to 16·7 mmol glucose/l, 10 mmol leucine/l and 10 mmol 2-ketoisocaproate/l in a monophasic fashion with no significant rise in the second phase. However, compared with the C group, a significant increase in the second-phase secretion in response to glucose and 2-ketoisocaproate was observed in the SH group, although there was no difference in the first-phase secretion. In the HH group the insulin secretion was lower in the first phase but not in the second phase. After culture for 7 days, B cells in the C group showed a biphasic response to the secretagogues, with a great increase in the second-phase secretion. In the SH group, the second phase of insulin secretion was increased but the increment was far less than that in the C group. The secretory response was remarkably low in the HH group compared with other groups. From these results, we conclude that at an early stage of culture slight maternal hyperglycaemia causes a hypersensitivity of neonatal B cells but impairs the normal development of the function of B cells during culture, and that high hyperglycaemia results in impaired insulin secretion throughout the whole period of culture studied.

J. Endocr. (1988) 119, 493–499

Restricted access